BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27342123)

  • 1. Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors.
    Fazio F; Lionetto L; Curto M; Iacovelli L; Copeland CS; Neale SA; Bruno V; Battaglia G; Salt TE; Nicoletti F
    Neuropharmacology; 2017 Jan; 112(Pt B):365-372. PubMed ID: 27342123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors.
    Fazio F; Lionetto L; Molinaro G; Bertrand HO; Acher F; Ngomba RT; Notartomaso S; Curini M; Rosati O; Scarselli P; Di Marco R; Battaglia G; Bruno V; Simmaco M; Pin JP; Nicoletti F; Goudet C
    Mol Pharmacol; 2012 May; 81(5):643-56. PubMed ID: 22311707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia.
    Fazio F; Lionetto L; Curto M; Iacovelli L; Cavallari M; Zappulla C; Ulivieri M; Napoletano F; Capi M; Corigliano V; Scaccianoce S; Caruso A; Miele J; De Fusco A; Di Menna L; Comparelli A; De Carolis A; Gradini R; Nisticò R; De Blasi A; Girardi P; Bruno V; Battaglia G; Nicoletti F; Simmaco M
    Sci Rep; 2015 Dec; 5():17799. PubMed ID: 26643205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of Xanthurenic acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus.
    Copeland CS; Neale SA; Salt TE
    Neuropharmacology; 2013 Mar; 66():133-42. PubMed ID: 22491023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
    Fazio F; Zappulla C; Notartomaso S; Busceti C; Bessede A; Scarselli P; Vacca C; Gargaro M; Volpi C; Allegrucci M; Lionetto L; Simmaco M; Belladonna ML; Nicoletti F; Fallarino F
    Neuropharmacology; 2014 Jun; 81():237-43. PubMed ID: 24565643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia.
    Ulivieri M; Wierońska JM; Lionetto L; Martinello K; Cieslik P; Chocyk A; Curto M; Di Menna L; Iacovelli L; Traficante A; Liberatore F; Mascio G; Antenucci N; Giannino G; Vergassola M; Pittaluga A; Bruno V; Battaglia G; Fucile S; Simmaco M; Nicoletti F; Pilc A; Fazio F
    Schizophr Bull; 2020 Dec; 46(6):1471-1481. PubMed ID: 32506121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An expanding range of targets for kynurenine metabolites of tryptophan.
    Stone TW; Stoy N; Darlington LG
    Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review on the Role and Function of Cinnabarinic Acid, a "Forgotten" Metabolite of the Kynurenine Pathway.
    Gawel K
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway.
    Fukuyama K; Tanahashi S; Hoshikawa M; Shinagawa R; Okada M
    Neuropharmacology; 2014 Jan; 76 Pt A():137-45. PubMed ID: 23973311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
    Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
    J Headache Pain; 2015; 17():47. PubMed ID: 27130315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites.
    Fukuyama K; Okada M
    Br J Pharmacol; 2018 Nov; 175(22):4253-4265. PubMed ID: 30153331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain: Neurochemical Characterization and Physiological Effects.
    Sathyasaikumar KV; Tararina M; Wu HQ; Neale SA; Weisz F; Salt TE; Schwarcz R
    Neuroscience; 2017 Dec; 367():85-97. PubMed ID: 29031603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid.
    Haruki H; Hovius R; Pedersen MG; Johnsson K
    J Biol Chem; 2016 Jan; 291(2):652-7. PubMed ID: 26565027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kynurenines in pathogenesis of endogenous psychiatric disorders].
    Shilov IuE; Bezrukov MV
    Vestn Ross Akad Med Nauk; 2013; (1):35-41. PubMed ID: 23805637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting metabotropic glutamate receptors for the treatment of neuroinflammation.
    Fazio F; Ulivieri M; Volpi C; Gargaro M; Fallarino F
    Curr Opin Pharmacol; 2018 Feb; 38():16-23. PubMed ID: 29471184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine metabolism and xanthurenic acid formation in vitamin B6-deficient rat after tryptophan injection.
    Takeuchi F; Tsubouchi R; Izuta S; Shibata Y
    J Nutr Sci Vitaminol (Tokyo); 1989 Apr; 35(2):111-22. PubMed ID: 2732805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. -electronic structures of tryptophan metabolites. II. 2-Aminoacetophenone, xanthurenic acid, cinnabarinic acid and related compounds.
    Tanaka H; Oira H; Kido R
    Wakayama Med Rep; 1971 Jan; 14(3):113-9. PubMed ID: 5571189
    [No Abstract]   [Full Text] [Related]  

  • 18. Unstability of cinnabarinic acid, an endogenous metabolite of tryptophan, under situations mimicking physiological conditions.
    Gómez-Piñeiro RJ; Dali M; Mansuy D; Boucher JL
    Biochimie; 2022 Aug; 199():150-157. PubMed ID: 35469990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of kynurenic and xanthurenic acids from kynurenine and 3-hydroxykynurenine in the dinoflagellate Lingulodinium polyedrum: role of a novel, oxidative pathway.
    Zsizsik BK; Hardeland R
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Nov; 133(3):383-92. PubMed ID: 12379423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors.
    Neale SA; Copeland CS; Uebele VN; Thomson FJ; Salt TE
    Neuropsychopharmacology; 2013 May; 38(6):1060-7. PubMed ID: 23303071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.